EcoDrugPlus

Histone Deacetylase 11

Ensembl ID : ENSMPUG00000017271
Gene Symbol: HDAC11
2 Cross references
197 Possible Orthologues:

Histone Deacetylase 2

Ensembl ID : ENSMPUG00000010268
Gene Symbol: HDAC2
2 Cross references
202 Possible Orthologues:

Histone Deacetylase 3

Ensembl ID : ENSMPUG00000008187
Gene Symbol: HDAC3
2 Cross references
156 Possible Orthologues:

Histone Deacetylase 4

Ensembl ID : ENSMPUG00000000127
Gene Symbol: HDAC4
2 Cross references
263 Possible Orthologues:

Histone Deacetylase 5

Ensembl ID : ENSMPUG00000009528
Gene Symbol: HDAC5
4 Cross references
194 Possible Orthologues:

Histone Deacetylase 6

Ensembl ID : ENSMPUG00000013660
Gene Symbol: HDAC6
4 Cross references
183 Possible Orthologues:

Histone Deacetylase 7

Ensembl ID : ENSMPUG00000000416
Gene Symbol: HDAC7
2 Cross references
260 Possible Orthologues:

Histone Deacetylase 8

Ensembl ID : ENSMPUG00000005345
Gene Symbol: HDAC8
1 Cross references
202 Possible Orthologues:

Histone Deacetylase 9

Ensembl ID : ENSMPUG00000013952
Gene Symbol: HDAC9
2 Cross references
234 Possible Orthologues:

Hydroxysteroid 11-Beta Dehydrogenase 1

Ensembl ID : ENSMPUG00000002995
Gene Symbol: HSD11B1
2 Cross references
248 Possible Orthologues:

Hyperpolarization Activated Cyclic Nucleotide Gated Potassium Channel 4

Ensembl ID : ENSMPUG00000017229
Gene Symbol: HCN4
2 Cross references
287 Possible Orthologues:

Hypocretin Receptor 1

Ensembl ID : ENSMPUG00000015430
Gene Symbol: HCRTR1
2 Cross references
96 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).